Nonopioid pain management after hip surgery
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
PHASE4 · Mayo Clinic · NCT05076110
This study is testing whether a mix of nonopioid medications can effectively manage pain after hip surgery without using narcotics.
Quick facts
| Phase | PHASE4 |
|---|---|
| Study type | Interventional |
| Enrollment | 188 (estimated) |
| Ages | 16 Years to 60 Years |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT05076110 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a pain control regimen that avoids narcotic medications following hip arthroscopy procedures. It involves administering a combination of nonopioid medications, including ibuprofen, gabapentin, acetaminophen, and methocarbamol, to manage post-operative pain. The goal is to determine if this approach can provide adequate pain relief while minimizing the risks associated with opioid use. The study is being conducted at the Mayo Clinic in Rochester, Minnesota.
Who should consider this trial
Good fit: Ideal candidates are individuals scheduled for primary hip arthroscopy at the Mayo Clinic.
Not a fit: Patients with a history of allergies to the study medications, substance abuse issues, or certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to safer pain management options for patients undergoing hip surgery.
How similar studies have performed: Other studies have shown promising results with nonopioid pain management strategies, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN) Exclusion Criteria: * medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin. * Substantial alcohol or drug abuse. * History of narcotics within 6 months of surgery. * Pregnancy. * Renal impairment. * Peptic ulcer disease. * GI bleeding.
Where this trial is running
Rochester, Minnesota
- Mayo clinic — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Kelechi Okoroha, MD — Mayo Clinic
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hip Arthroscopy